Immucor and Pirche announce multi-year partnership
October 04, 2022 08:04 ET
|
Immucor, Inc.
NORCROSS, Ga. and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global leader in AI-powered molecular...
Immucor Announces New Innovations in Transplant Diagnostics
March 04, 2022 13:18 ET
|
Immucor, Inc.
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics announced two additions to its transplant diagnostics portfolio,...
Palmetto GBA Finalizes Local Coverage Determination (LCD) for Liquid Biopsies for Solid Organ Transplantation, Including Immucor’s kSORT Assay
April 26, 2021 15:10 ET
|
Immucor, Inc.
Significant Achievement for kSORT Commercialization and Continued Innovation in Post-Transplant Monitoring LCD Covers Test for Eligible Transplant Recipients on Medicare NORCROSS, Ga., April 26,...
Immucor Announces Successful Refinancing
July 07, 2020 16:39 ET
|
Immucor, Inc.
NORCROSS, Ga., July 07, 2020 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced the successful completion of the refinancing of its...
Immucor Announces Health Canada Approval for NEO Iris™; Next Generation, Fully Automated Instrument for Transfusion Medicine
April 30, 2019 12:21 ET
|
Immucor, Inc.
NORCROSS, Ga., April 30, 2019 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next generation, fully automated NEO®...
UPDATE - Immucor Announces Health Canada Approval for Echo Lumena™; Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
January 11, 2019 17:00 ET
|
Immucor, Inc.
NORCROSS, Ga., Jan. 11, 2019 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next generation, fully automated Echo®...
Immucor Announces Health Canada Approval for Echo Echo Lumena™; Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
January 11, 2019 14:48 ET
|
Immucor, Inc.
NORCROSS, Ga., Jan. 11, 2019 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next generation, fully automated Echo®...
Immucor Announces FDA Clearance for NEO Iris™; Next Generation, Fully Automated Instrument for Transfusion Medicine
November 08, 2018 14:46 ET
|
Immucor, Inc.
Highest throughput for immunohematology now powered with clearer results for brilliant performance NORCROSS, Ga., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and...
Immucor Announces FDA Clearance for Echo Lumena(TM); Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
April 30, 2018 17:25 ET
|
Immucor, Inc.
NORCROSS, Ga., April 30, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next generation, fully automated Echo®...
Avi Pelossof Appointed President and CEO of Immucor
January 16, 2018 09:00 ET
|
Immucor, Inc.
NORCROSS, Ga., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics and a portfolio company of global alternative asset firm TPG, today...